EAVI2020 EAVI2020 on Twitter EAVI2020 on LinkedIn

Polymun Scientific Immunbiologische Forschung GmbH

Polymun is a privately held CMO near Vienna, Austria, founded in 1992 with more than 60 employees. Our core activities are contract development and manufacturing of biopharmaceuticals as well as liposomal formulations. Polymun operates in accordance with GMP guidelines meeting all EU requirements for drug manufacturing.

Polymun is responsible for process development and GMP production of HIV envelope proteins as well as novel T helper liposomes, including release and stability testing. Furthermore, Polymun is in charge of GMP production of adjuvant such as liposomal MPLA.


Dr. Dietmar Katinger

Dietmar Katinger studied food- and biotechnology and the University of Natural Resources and Life Sciences, Vienna, Austria, graduating in 1994 with a master thesis about HIV antibodies. He finished his PhD thesis in 1999 about development and production of a life-attenuated influenza vaccine using mammalian cell culture. Furthermore, he graduated as MBA in 2006. Since 2003, Dietmar Katinger was responsible for business affairs at Polymun and is CEO of Polymun since December 2010.